Novo Nordisk A/S (NVO)
47.45
-1.00
(-2.06%)
USD |
NYSE |
Feb 20, 13:23
Novo Nordisk EPS Diluted (Quarterly) : 0.9419 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Ascendis Pharma A/S | -0.6364 |
| Evaxion AS | -0.2862 |
| Regeneron Pharmaceuticals, Inc. | 7.857 |
| Viking Therapeutics, Inc. | -1.383 |
| DBV Technologies SA | -1.207 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 4.191B |
| Revenue (Quarterly) | 12.33B |
| Total Expenses (Quarterly) | 8.143B |
| Enterprise Value | 231.80B |
| Gross Profit Margin (Quarterly) | 80.86% |
| Profit Margin (Quarterly) | 33.98% |
| Earnings Yield | 7.31% |
| Operating Earnings Yield | 9.11% |
| Normalized Earnings Yield | 7.309 |